← Back to headlines
Coherus Aims for $15M Quarterly LOQTORZI Sales by 2026
Coherus BioSciences is targeting $15 million in quarterly LOQTORZI sales by 2026, while also progressing with midyear readouts for tagmokitug and casdozokitug.
12 May, 13:52 — 12 May, 13:52
Sources
Showing 1 of 1 sources



